




<rss xmlns:a10="http://www.w3.org/2005/Atom" version="2.0">
    <channel>
        <title>Acute Heart Failure</title>
        <link>http://www.acc.org/Feed?clinicalTopicID=729dd08e-0a1b-4aa5-bd2a-5e3f31006cb0</link>
        <description>Clinical Topic Feed: Acute Heart Failure</description>
        <language>en</language>

        

                <item>
                    <title>DIGIT-HF Analysis and DECISION Analysis: New Insights on Digitoxin and Digoxin</title>
<link>/Latest-in-Cardiology/Journal-Scans/2026/05/18/18/10/DIGIT-HF-Analysis-and-DECISION-Analysis</link>                    <description>Digitoxin appears to be safe and effective in patients with heart failure with reduced ejection fraction (HFrEF), including those with atrial fibrillation (AFib), according to an analysis from DIGIT-HF, while digoxin discontinuation after long-term treatment was associated with clinical deterioration in patients with HF and LVEF &#226;‰&#164;50%, according to an analysis from DECISION. Both were published recently in EHJ.</description>
                    <pubdate>1779370200000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>PRAISE-MR: Sacubitril/Valsartan Improves Exercise Hemodynamics, Oxygen Consumption</title>
<link>/Latest-in-Cardiology/Journal-Scans/2026/05/18/18/10/PRAISE-MR</link>                    <description>In patients with atrial functional mitral regurgitation (AFMR) and heart failure with reduced ejection fraction (HFpEF), sacubitril/valsartan was associated with improvements in exercise hemodynamics and peak oxygen consumption (VO2), along with attenuation of an exercised-induced increase in AFMR...</description>
                    <pubdate>1779370200000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Eagle&#226;€™s Eye View: Imaging Identifies HCM Patients at High-Risk of Adverse Outcomes </title>
<link>/Latest-in-Cardiology/Articles/2026/05/20/13/40/eagles-eye-view-20may2026</link>                    <description>In this week&#226;€™s View, Dr. Eagle reviews evidence supporting the use of cardiac magnetic resonance (CMR) and NT-proBNP in hypertrophic cardiomyopathy (HCM) risk assessment.</description>
                    <pubdate>1779288780000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>JACC Spotlight Issue Provides Expert Insight on 2026 Dyslipidemia Guideline</title>
<link>/Latest-in-Cardiology/Articles/2026/05/19/15/49/JACC-Spotlight-Issue-2026-Dyslipidemia-Guideline</link>                    <description>A special JACC Spotlight Issue supporting the recently published 2026 ACC/AHA Guideline on the Management of Dyslipidemia, offers commentaries that provide a comprehensive overview of the new guideline recommendations and expert insights into understanding the science behind the recommendations...</description>
                    <pubdate>1779206040000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>ACC CardiaCast: In Case You Missed It: ACC.26 ATTR-CM Treatment Updates</title>
<link>/Latest-in-Cardiology/Articles/2026/05/15/12/43/cardiacast_18may2026</link>                    <description>This CardiaCast episode explores the latest advances in transthyretin amyloid cardiomyopathy (ATTR-CM) presented at ACC.26, with a focused review of newly released late-stage clinical trial data for currently available disease-modifying therapies.</description>
                    <pubdate>1779118200000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Clinical Obesity Emerges as Independent Risk Factor For New-Onset HF, Mortality</title>
<link>/Latest-in-Cardiology/Journal-Scans/2026/05/14/17/42/Clinical Obesity</link>                    <description>A cohort study published May 4 in JACC: Asia identified clinical obesity as a risk factor for new-onset heart failure (HF) and all-cause mortality, largely due to related clinical conditions and excess weight. Treating clinical obesity as an independent disease may increase the effectiveness of HF prevention strategies.</description>
                    <pubdate>1778782020000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>&#226;€&#175;Eagle&#226;€™s Eye View: Can Rhythm Control Improve Tricuspid Regurgitation? </title>
<link>/Latest-in-Cardiology/Articles/2026/05/12/15/21/eagles-eye-view-13may2026</link>                    <description>In this week&#226;€™s View, Dr. Eagle examines the role of rhythm control in improving moderate-to-severe and severe secondary tricuspid valve regurgitation.</description>
                    <pubdate>1778679000000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>FASTR: Reprieve System Safely Accelerates Decongestion in Acute HF</title>
<link>/Latest-in-Cardiology/Journal-Scans/2026/05/11/15/12/FASTR</link>                    <description>The Reprieve System, a three-part approach to diuretic therapy, safely produced significantly faster decongestion in patients with acute heart failure (HF) compared with optimal diuretic therapy (ODT), according to results of the FASTR trial published May 4 in JACC: Heart Failure.</description>
                    <pubdate>1778670960000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>JACC Journals Science at ESC Heart Failure Congress 2026</title>
<link>/Latest-in-Cardiology/Journal-Scans/2026/05/11/15/12/JACC-Journals-Science-at-ESC-Heart-Failure-Congress-2026</link>                    <description>Findings from several studies presented at ESC Heart Failure Congress 2026 in Barcelona, Spain, were simultaneously published in JACC and JACC: Heart Failure, covering topics like arrhythmic burden in cardiac amyloidosis (CA), stroke and bleeding risk in CA...</description>
                    <pubdate>1778607960000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>ACC CardiaCast: Hemodynamic Insights: Understanding Data and Impact   </title>
<link>/Latest-in-Cardiology/Articles/2026/05/08/14/35/cardiacast_11may2026</link>                    <description>This episode is part of ACC&#226;€™s ongoing initiative to advance education on remote hemodynamic monitoring in heart failure management.</description>
                    <pubdate>1778515200000</pubdate>
                    <category>Articles and Stories</category>
                </item>

    </channel>
</rss>